Edition:
United Kingdom

ARCA Biopharma Inc (ABIO.OQ)

ABIO.OQ on NASDAQ Stock Exchange Capital Market

1.48USD
21 Nov 2017
Change (% chg)

-- (--)
Prev Close
$1.48
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
22,668
52-wk High
$3.00
52-wk Low
$1.05

Select another date:

Thu, Nov 16 2017

BRIEF-Arca Biopharma announces issuance of European patent on cardiovascular disease treatment methods

* Arca Biopharma announces issuance of European patent for treating cardiovascular diseases and conditions with a new chemical entity utilizing genetic targeting

BRIEF-ARCA Biopharma announces third quarter financial results

* ARCA Biopharma announces third quarter 2017 financial results and provides business update

BRIEF-ARCA Biopharma to share top-line results in Q1 next year for GENETIC-AF trial​

* ARCA Biopharma announces GENETIC-AF data and safety monitoring board recommendation to complete Phase 2B GENETIC-AF clinical trial based on efficacy and safety data in phase 2b interim analysis

BRIEF-Arca Biopharma Q2 loss per share $0.59

* Arca Biopharma announces second quarter 2017 financial results and provides business update

BRIEF-ARCA Biopharma announces database lock for genetic-af phase 2b interim efficacy analysis

* ARCA Biopharma announces database lock for genetic-af phase 2b interim efficacy analysis – dsmb recommendation anticipated in august 2017 Source text for Eikon: Further company coverage:

Select another date: